The purpose of this chapter is to provide practical chemical ligation procedures to prepare histone proteins suitable for the reconstitution of nucleosomes with speci fi c posttranslational modi fi cations in the nucleosome core. Detailed methods are described for the ef fi cient preparation of semisynthetic histones H3 and H4 with modi fi cations near the C-terminus of the proteins by expressed protein ligation and desulfurization. Additionally, we present optimized protocols for solid phase peptide synthesis combined with sequential native chemical ligation to generate fully synthetic modi fi ed histone H3, here in the context of H3 lysine 56 acetylation (H3K56ac).
Introduction
approximately 30% of the histone sequence, PTMs also occur throughout the structured nucleosome core ( 2 ) . These modi fi cations are found in distinct regions of the histone-DNA interface and may facilitate varied dynamic events within the nucleosome, such as DNA unwrapping, nucleosome assembly or disassembly, and chromatin remodeling ( 3, 4 ) .
Chemical ligation is an excellent way to prepare the homogenous samples of precisely modi fi ed histone proteins that are necessary to characterize the molecular functions of these modi fi cations within the structured nucleosome core ( 5 ) . Native chemical ligation (NCL) is the chemoselective condensation of two polypeptides, one with a C-terminal a -thioester and one with a 1,2-aminothiol, typically an N-terminal cysteine, resulting in the formation of a native amide bond at the ligation site. These two segments may be generated using recombinant techniques (expressed protein ligation) or synthetically. Synthetic peptides are not limited to the 20 natural amino acids and can be chemically diverse. For example, peptides can be synthesized with PTMs such as acetylation and phosphorylation. Ligation to generate a fulllength protein, such as a histone, site-speci fi cally incorporates these chemical modi fi cations into the histone sequence. These modi fi ed histones are then combined with the unmodi fi ed, recombinant core histones and reconstituted into nucleosomes and nucleosome arrays.
This chapter describes the techniques used to introduce modi fi cations into the nucleosome core using chemical ligation. We have used these strategies to introduce acetylation and phosphorylation into histones H3 and H4 (6) (7) (8) , but they are applicable to any modi fi cation compatible with peptide synthesis. We describe semisynthetic and fully synthetic approaches to histone preparation and the considerations required for each.
There are multiple variants of chemical ligation that are applicable to histones (Fig. 1 ) . Expressed protein ligation (EPL) combines synthetic peptide segments with recombinant protein segments. This powerful approach can generate multiple milligrams of material but is limited to the introduction of clusters of modi fi cations close to the N-or C-terminus of a histone protein. In this chapter, we will discuss how this technique has been applied to the preparation of modi fi ed histone H3 suitable to study modi fi cations in the nucleosome dyad ( 3, 6, 7 ) and acetylated histone H4 to study modi fi cations in the LRS (loss of rDNA silencing) region of the nucleosome ( 4 ) .
Sequential native chemical ligation is the most fl exible technique to introduce PTMs throughout the protein sequence ( 8 ) . In this approach, each peptide segment is generated synthetically and linked via ligation. Since this total synthesis approach is labor intensive and yields smaller amounts of homogenous material, it is most
General Considerations
suitable for sensitive biochemical or biophysical characterization of nucleosomes. However, it is the only method by which any combination of PTMs may be introduced across the protein sequence and is limited in scope only by the ability to prepare the appropriate modi fi ed peptide segments. This technique has been demonstrated in the preparation of histone H3 acetylated at lysine 56 (H3K56ac).
In each case, consideration must be paid to the selection of appropriate ligation junctions. Native chemical ligation typically requires an N-terminal cysteine for reaction to occur; this leaves a residual Cys at the ligation site. Histone proteins have very few natural cysteines. Most histone H3 variants include a single Cys at position 110, and an additional Cys is present at position 96 in the human histone variants 3.1 and 3.1t ( 9 ) . Interestingly, both of these Cys are dispensable, and a C110A substitution that is native in yeast H3 sequences is often used for biophysical studies of the nucleosome ( 10 ) . However, H3-C110 is a convenient ligation site for the semisynthesis of histone H3 with PTMs in the nucleosome dyad and can be used to generate the canonical X. laevis histone H3 sequence.
Although a 1,2-aminothiol is required for ligation, ligation junctions are not limited to Cys sites. Desulfurization reactions can be used to convert a ligation-capable 1,2-aminothiol to a cognate amine ( 11 ) . This is most often used to convert a ligation-site Cys to Ala after ligation is complete, such that in the context of a protein with no essential Cys in the sequence, Ala can be considered a potential ligation site. Histone H4 has no native Cys residues, so H4-His 75 -Ala 76 is a convenient junction in a ligation-desulfurization strategy to introduce modi fi cations near the C-terminus of the protein. In the total synthesis of histone H3, the H3-C110A substitution eliminates the only native Cys, and desulfurization after ligation using A47 and A91 as ligation junctions generates a nativelike sequence. 3. Triton wash buffer: 25 mM HEPES, pH 7.5, 1.0 mM EDTA, 1.0 M NaCl, and 1% Triton-X.
4. Pellet wash buffer: 25 mM HEPES, pH 7.5, 1.0 mM EDTA, and 1.0 M NaCl.
Dimethyl sulfoxide (DMSO).
6. HU-0, HU-100, HU-400, HU-500, and HU-1000 buffer: 6 M urea, 25 mM HEPES, pH 7.5, and 1.0 mM EDTA, with 0, 100, 400, and 500 mM, and 1.0 M NaCl, respectively.
7. 5 mL SP-FF ion exchange column (GE Healthcare).
8. Refolding buffer: 25 mM HEPES, pH 7.5, 1.0 mM EDTA, and 1.0 M NaCl.
9. Spectra/Por dialysis tubing, MWCO 6-8 kDa; gently boil in 1.0 mM EDTA with three buffer changes and store at 4°C.
10. Ultrapure guanidine (Gdn) hydrochloride and urea (MP Biomedical).
11. Sodium 2-mercaptoethanesulfonic acid (MESNA).
12. Vivaspin 5 kDa MWCO protein concentrator (BioExpress). 3. Ligation buffer A: 6 M urea, 25 mM HEPES pH 7.5, 1.0 M NaCl, 1.0 mM EDTA, and 50 mM MESNA.
4. Ligation buffer B: 6 M Gdn, 25 mM HEPES pH 7.5, 1.0 M NaCl, 1.0 mM EDTA, and 50 mM MESNA.
5. Ligation buffer C: 6 M Gdn, 100 mM phosphate buffer pH 7.5, 500 mM NaCl, 50 mM MESNA, and 10 mM TCEP.
6. Supelco Discovery BIO Wide Pore C18 RP-HPLC columns in analytical, semi-preparative, and preparative scales.
7. TU buffer: 10 mM tris(hydroxymethyl)aminomethane (Tris), pH 9.0, 7 M urea, 1.0 mM EDTA, and 5 mM b -mercaptoethanol (BME). TU-100 includes 100 mM NaCl, and TU-600 includes 600 mM NaCl.
8. Spectra/Por dialysis tubing, MWCO 6-8 kDa; gently boil in 1.0 mM EDTA with three buffer changes and store at 4°C.
9. TSKgel SP-5PW column (TOSOH Biosciences).
Trichloroacetic acid (TCA).
2. 5 N NaOH stock solution.
1. Methoxylamine hydrochloride.
1. VA-044US (Wako Chemicals).
Sodium 2-mercaptoethanesulfonic acid (MESNA).
3. TCEP stock solution: 1.2 M TCEP, pH 7.5.
4. Millipore ZipTip C18 pipette tips, P10 size.
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TCA Precipitation
Thiazolidine Ring Opening
Free-Radical Desulfurization to Generate
Native Protein Sequences
Tri fl uoroacetic acid (TFA).
2. Dimethyl sul fi de.
Sodium iodide (NaI).
Synthesis or semisynthesis of modi fi ed histone proteins is a multistep process. These methods will describe the preparation of recombinant (Subheading 3.1 ) and synthetic (Subheading 3.2 ) polypeptide components for expressed protein ligation (Subheading 3.3 ) to generate semisynthetic histones H3 and H4 with clusters of modi fi cations as separate procedures. Similarly, the preparation of synthetic peptide segments (Subheading 3.2 ) for sequential native chemical ligation (Subheading 3.4 ) to prepare fully synthetic histone H3 will be described. A working knowledge of basic peptide synthesis techniques will be assumed, and only protocols speci fi c to these polypeptides will be presented in detail.
Recombinant histone thioesters are prepared by the thiolysis of the histone N-terminal domain fused with a structured intein and a C-terminal chitin-binding domain (CBD) tag. However, these fusion proteins express as misfolded aggregates that accumulate in inclusion bodies. The general steps required to prepare the histone thioester are expression of the fusion protein, puri fi cation of inclusion bodies, refolding to generate the functional intein domain, and thiolysis to produce the histone thioester for ligation. Refolding and thiolysis of the histone-intein-CBD is time sensitive. Once the intein is refolded it becomes active and is susceptible to hydrolysis, which diminishes product yield. Also note that buffers should not contain any thiols except where speci fi cally instructed; in particular avoid the use of dithiothreitol or b -mercaptoethanol, which lead to nonproductive intein cleavage. 4. Spin lysate at 20,000 × g for 15 min at 4°C. Histone-intein fusion will be found in the pellet.
5. Resuspend pellet in 25 mL Triton wash buffer. Centrifuge at 10,000 × g for 10 min at 4°C. Pour off supernatant. Repeat this wash step.
6. Resuspend pellet in 25 mL pellet wash buffer. Centrifuge at 10,000 × g for 10 min at 4°C. Pour off supernatant. Repeat the wash step. The pellet may be stored at −80°C.
7. Thaw pellet on ice. Once thawed, add 250 m L DMSO and mince the pellet with a spatula. Allow to soak at 25°C for 30 min.
8. Add 30 mL HU-500 buffer to the pellet and resuspend by mixing for 1 h at room temperature. Centrifuge at 15,000 × g for 10 min at 25°C; save the supernatant. Repeat step 8 .
9. Test each supernatant from step 8 for the presence of protein by analysis on a 15% SDS-PAGE gel; if appropriate, combine the supernatants. Dilute with HU-0 to reach 100 mM NaCl or dialyze overnight against HU-100 buffer.
10. Split in half, and purify each batch by ion exchange over 5 mL SP-FF column according to manufacturer's instructions. Load sample, wash with HU-100 buffer, and elute protein with HU-500 buffer. Analyze eluent by SDS-PAGE; combine fractions containing histone-intein-CBD.
1. Dilute puri fi ed protein to 30-50 mL using HU-1000 and dialyze fractions overnight against 4 L of refolding buffer at 4°C. Some protein will precipitate, but the majority should be properly refolded protein in the supernatant. If suf fi cient protein is lost, the pellet may be resuspended in HU-1000 and refolded by dialysis a second time.
2. In a 50 mL conical tube, add MESNA to the refolded histoneintein-CBD to a fi nal concentration of 100 mM. Nutate at 4°C for 18-24 h.
3. For H3 thioester, add ultrapure urea, adjust buffer components to compensate for the change in volume, and modify pH to reach a fi nal ligation buffer A composition.
4. For H4 thioester, add ultrapure guanidine, adjust buffer components to compensate for the change in volume, and modify pH to reach fi nal ligation buffer B composition. (Table 2 ). These peptides are each ~45 amino acids in length and can be synthetically challenging. The requirement for an a -thioester in peptides H3N and H3M provides an additional challenge. This section will describe the syntheses of the peptides used to generate H3K56ac by Boc-SPPS chemistry, as described in Shimko et al. ( 8 ) . Appropriate peptides for the preparation of other modi fi ed histones may be synthesized similarly. 3. H3C may be prepared by Boc-SPPS using in situ neutralization protocols ( 14 ) . Single coupling cycles can be used for the addition of the fi rst 20 amino acids; double coupling cycles should be used for each subsequent residue. Acetylation/capping cycles should be used throughout to minimize deletion sequences and simplify puri fi cation.
4. H3C may be prepared by Fmoc-SPPS using HCTU activation. We recommend double coupling cycles after the fi rst 20 amino acids and the use of acetylation/capping cycles to simplify puri fi cation.
5. Purify H3C by RP-HPLC using a gradient of 25-45% buffer B.
Among the columns we have tested, Supelco Discovery BIO Wide Pore C18 columns provide the best resolution and yield for these histone peptides.
1. Peptide H3N corresponds to H3(1-46) thioester. H3M is the central segment of fully synthetic H3, with both a masked N-terminal Cys and a C-terminal thioester, and corresponds to H3(47-90)-A47Thz,K56ac ( see Notes 1 and 2 ).
2. Thioester peptides H3N and H3M may be prepared by Boc-SPPS on mercaptopropionamide substituted resin ( 12 ) using in situ neutralization protocols with single coupling cycles for the fi rst 20 amino acids, double coupling cycles through the remainder of the sequence, and capping cycles to simplify puri fi cation. The acetylated lysine is introduced as Boc-Lys(Ac)-OH. For peptide H3M, the N-terminal Cys is introduced as Bocthiazolidine-OH to avoid intramolecular ligation.
3. Purify H3N and H3M by RP-HPLC with gradients of 10-25% buffer B and 35-55% buffer B, respectively. 2. The pH of the fi nal ligation mixture should be assessed by spotting 0.2 m L of the reaction mixture onto pH paper at 0 and 2 h. If necessary, pH should be adjusted to 7.5 by the addition of 1.0 M HCl or NaOH.
Reaction proceeds overnight or until no further ligation is assessed by analysis on a 15% SDS-PAGE gel ( see Note 3 ).
Care should be taken to transfer the gel to stain or a fi xing solution immediately in order to minimize diffusion of peptide from the gel prior to analysis.
4. Dialyze products into Milli-Q H 2 O overnight.
5. Transfer contents of the dialysis bag to a 50 mL conical tube, taking care to recover any precipitate, and lyophilize to dryness.
6. Resuspend products in TU-100 and purify by ion exchange HPLC over a TSKgel SP-5PW column with a gradient of TU-100 to TU-600 (600 mM NaCl).
7. Assess puri fi cation fractions by 15% SDS-PAGE. The fulllength H3 product will not separate fully from residual truncated H3 ( see Note 4 ) . If the semisynthetic histone is to be used to generate histone octamer for nucleosome reconstitutions, each fraction containing more than 50:50 ratio of fulllength protein to truncated histone should be combined. The histone will be further puri fi ed during histone octamer refolding since the peptide comprises an essential interface in the folded octamer. 4. Histone H4 may be puri fi ed either by ion exchange over a TSKgel SP-5PW column as per Subheading 3.3.1 , steps 4 -6 , or by RP-HPLC using a gradient of 35-65% buffer B. Typically, acetylated H4 is compatible with RP-HPLC puri fi cation, but
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H4-pT80 co-elutes with int-CBD by RP-HPLC so must be puri fi ed by ion exchange ( see Note 5 ).
5. If the modi fi ed histones will be used to refold histone octamers, H4(1-75) may be co-puri fi ed with full-length protein to maximize yield ( see Note 4 ).
1. Resuspend H3M peptide and 2.2 molar equivalents of H3C peptide independently in ligation buffer C, monitoring solubility carefully.
2. Combine resuspended peptides and allow ligation to proceed with mixing by nutation at room temperature ( see Note 3 ).
3. Reaction progress may be monitored by RP-HPLC. However, peptide H3M and product H3MC are only mildly soluble in acidic RP-HPLC conditions, so chromatograms may be deceptive. We typically monitor reaction both by SDS-PAGE following TCA precipitation (Subheading 3.5.1 ) as well as RP-HPLC. Reaction is allowed to proceed until no further product formation is observed (typically 2 days).
4. After reaction is complete, add methoxylamine to the crude ligation mixture (400 mM) according to Protocol 3.5.2 to convert Thz to Cys. Deprotection typically takes 6 h for this ligation product. Peptide H3N has a b -branched Val as the C-terminal amino acid. This ligation terminus has poor kinetics ( 17 ) , and the reaction can take up to 5 days to reach maximal yield, depending on the choice of co-thiol for this reaction. Ligation is slow with the MESNA thioester and typically does not go to completion. Ligation with the MPAA thioester typically proceeds faster and generates more of the desired product, but MPAA quenches desulfurization and must be removed prior to the conversion step. This protocol is written to re fl ect use of MESNA:
1. Independently resuspend H3MC and 5 molar equivalents of H3N in the minimal volume of ligation buffer C required to fully dissolve the pellets.
2. Combine the peptide aliquots to initiate ligation, and allow to react while mixing by nutation at room temperature ( see Note 3 ).
3. Monitor reaction progress by SDS-PAGE, using TCA precipitation (Subheading 3. Several buffer systems used in these protocols require guanidine, which is not compatible with SDS-PAGE analysis of thiolysis and ligation progress. TCA precipitation is used to isolate total protein content from buffer components in a sample:
2. Add 25 m L 100% (w/v) TCA, mix, and incubate at 4°C for 10 min.
3. Centrifuge at 16,000 × g and carefully remove supernatant without disturbing pellet.
4. Protein pellet may be resuspended directly without washing in SDS-PAGE loading buffer. Residual TCA is neutralized with the addition of NaOH as needed (typically 1 m L 5 N NaOH).
The condensation of an N-terminal Cys with formaldehyde generates thiazolidine, which serves as a masked N-terminal Cys during sequential ligation. The Cys can be regenerated by addition of an excess of methoxylamine under acidic conditions. 1. Care should be taken to avoid racemization of N-terminal Cys ( 19 ) . We introduce this residue as the Boc-thiazolidine-OH derivative (Bachem) to maintain stereochemistry and to allow for the removal of N-terminal protection during cleavage. Procedure 3.5.2 carried out on the crude peptide mixture unmasks the N-terminal Cys prior to puri fi cation.
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2. Peptides may also be synthesized with Norleucine (Nle) in place of Met. The Met to Nle substitution eliminates oxidation of Met as a possible side product and removes the need for protocol 3.5.4 .
3. The native chemical ligation reaction is sensitive to pH and should be continuously monitored over the course of a ligation to verify that a pH of ~7.5 is continuously maintained.
4. Semisynthetic histone with synthetic a C helix, such as H3 and H4 when prepared by these protocols, can be with the truncated recombinant histone sequence. After puri fi cation, each fraction containing greater than 50% full-length protein should be combined. Since the synthetic segment comprises the a C helix, an essential interface in the folded octamer, only fulllength histone will generate the full refolded histone octamer. Size exclusion puri fi cation of the octamer then removes any residual truncated protein. To set up refolding, histone content should be calculated such that recombinant histones are equimolar to the sum of full-length semisynthetic and truncated histone domain.
5. Histone proteins may be marginally soluble under desulfurization conditions or with addition of acetonitrile. Any precipitate which forms should be reclaimed, analyzed, and treated as required to maximize yield.
6. Trace aldehydes from glass or from buffer components can react with N-terminal Cys over the course of a lengthy ligation to form a Thz side product, typically observed as a shift in RP-HPLC retention and +12 Da by MALDI-TOF MS. If Thz is detected, add 200 mM methoxylamine and incubate until reversion to Cys is complete (typically 4 h). Ligation may be reinitiated by raising the pH to 7.5.
7. The common MPAA co-thiol quenches free-radical desulfurization and must be completely removed by dialysis prior to this protocol.
